Stina Singel

Chief Tech/Sci/R&D Officer at ASCENDIS PHARMA A/S

Net worth: 373 682 $ as of 29/04/2024

50 year

Health Technology

Consumer Services

Stina Singel active positions

Companies	Position	Start	End
ASCENDIS PHARMA A/S	Chief Tech/Sci/R&D Officer	30/04/2020	-

Companies	Position	Start	End
NEKTAR THERAPEUTICS	Corporate Officer/Principal	31/03/2019	30/04/2020
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Chief Tech/Sci/R&D Officer	28/02/2014	31/03/2019

University of California San Diego	Doctorate Degree
The Salk Institute for Biological Studies	Doctorate Degree
Harvard University	Undergraduate Degree

International

United States	6
Denmark	2

Operational

Chief Tech/Sci/R&D Officer	2
Doctorate Degree	2
Corporate Officer/Principal	1

Sectoral

Health Technology	4
Consumer Services	4

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
ASCENDIS PHARMA A/S	Health Technology
NEKTAR THERAPEUTICS	Health Technology

Private companies	1
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology

Private companies

Health Technology